Home › Acute Myeloid Leukemia
Pag-aaral pangklinika para sa Acute Myeloid Leukemia na nagre-recruit sa U.S.
276 pag-aaral para sa Acute Myeloid Leukemia ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Houston, TX85 pag-aaral
- New York City, NY51 pag-aaral
- Boston, MA44 pag-aaral
- Baldwin Park, CA40 pag-aaral
- Seattle, WA40 pag-aaral
- Columbus, OH35 pag-aaral
- Philadelphia, PA34 pag-aaral
- Durham, NC33 pag-aaral
- Atlanta, GA30 pag-aaral
- Tampa, FL29 pag-aaral
- Chicago, IL26 pag-aaral
- Portland, OR25 pag-aaral
- Miami, FL24 pag-aaral
- Washington, DC24 pag-aaral
- Los Angeles, CA24 pag-aaral
- St. Louis, MO22 pag-aaral
- Dallas, TX21 pag-aaral
- Nashville, TN21 pag-aaral
- Birmingham, AL21 pag-aaral
- Queens, NY21 pag-aaral
- Cincinnati, OH20 pag-aaral
- Cleveland, OH20 pag-aaral
- Edison, NJ20 pag-aaral
- Minneapolis, MN20 pag-aaral
- Buffalo, NY19 pag-aaral
- Mountain View, CA19 pag-aaral
- Baltimore, MD19 pag-aaral
- Pittsburgh, PA18 pag-aaral
- Winston-Salem, NC18 pag-aaral
- Greenburgh, NY18 pag-aaral
- Salt Lake City, UT17 pag-aaral
- Ann Arbor, MI17 pag-aaral
- New Haven, CT17 pag-aaral
- Milwaukee, WI17 pag-aaral
- Rochester, NY16 pag-aaral
- Charlotte, NC16 pag-aaral
- Aurora, CO16 pag-aaral
- Cedar Rapids, IA16 pag-aaral
- Charlottesville, VA16 pag-aaral
- Madison, WI16 pag-aaral
Ayos sa estado
- Alabama21 pag-aaral
- Arizona22 pag-aaral
- Arkansas13 pag-aaral
- California79 pag-aaral
- Colorado22 pag-aaral
- Connecticut17 pag-aaral
- Delaware7 pag-aaral
- District of Columbia10 pag-aaral
- Florida55 pag-aaral
- Georgia38 pag-aaral
- Hawaii7 pag-aaral
- Idaho9 pag-aaral
- Illinois31 pag-aaral
- Indiana14 pag-aaral
- Iowa17 pag-aaral
- Kansas20 pag-aaral
- Kentucky14 pag-aaral
- Louisiana13 pag-aaral
- Maine9 pag-aaral
- Maryland31 pag-aaral
- Massachusetts45 pag-aaral
- Michigan24 pag-aaral
- Minnesota27 pag-aaral
- Mississippi8 pag-aaral
- Missouri23 pag-aaral
- Montana6 pag-aaral
- Nebraska10 pag-aaral
- Nevada9 pag-aaral
- New Hampshire9 pag-aaral
- New Jersey32 pag-aaral
- New Mexico9 pag-aaral
- New York71 pag-aaral
- North Carolina43 pag-aaral
- North Dakota4 pag-aaral
- Ohio57 pag-aaral
- Oklahoma14 pag-aaral
- Oregon27 pag-aaral
- Pennsylvania45 pag-aaral
- Rhode Island11 pag-aaral
- South Carolina16 pag-aaral
- South Dakota6 pag-aaral
- Tennessee31 pag-aaral
- Texas94 pag-aaral
- Utah17 pag-aaral
- Vermont7 pag-aaral
- Virginia24 pag-aaral
- Washington41 pag-aaral
- West Virginia6 pag-aaral
- Wisconsin25 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)
Nagre-recruitPhase 2/3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07581002Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
Nagre-recruitPhase 2
Edad 60 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07437950Olutasidenib With Azacitidine Followed by Olutasidenib Maintenance for the Treatment of IDH1-mutated Acute Myeloid Leukemia in Patients With Prior Treatment With Venetoclax Plus a Hypomethylating Agent
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07304011Assessment of Geriatric Evaluations Impact on New AML Guidance
Nagre-recruitObservasyonal na pag-aaral
Edad 50 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT05909501Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies
Nagre-recruitPhase 1
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06904066Phase 1 Open-label Study of AMX-883 Alone in Participants With AML and High-risk MDS and in Combination in Participants With AML
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07723703Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT05334069Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06484062Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Nagre-recruitObservasyonal na pag-aaral
Edad 0 hanggang 38 · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06131801A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
Nagre-recruitPhase 1
Edad 12 hanggang 78 · Lahat ng kasarian · Na-update Set 29, 2026 · NCT03802695A Phase 1 Study of AOH1996 in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT06763341Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Nagre-recruitPhase 2
Edad 18 hanggang 59 · Lahat ng kasarian · Na-update Set 28, 2026 · NCT05554393A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06852222MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT05564390Liposome-encapsulated Daunorubicin-Cytarabine and Venetoclax in Treating Participants With Relapsed, Refractory or Untreated Acute Myeloid Leukemia
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT03629171A Phase 1B/2A Trial of NADUNOLIMAB in Combination With Azacitidine (With/Without Venetoclax) in Patients With Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML)
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06548230Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
Nagre-recruitPhase 3
Edad 12 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07211958Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT03874052Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
Nagre-recruitMaagang Phase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06398457Quizartinib, Decitabine, and Venetoclax in Treating Participants With Untreated or Relapsed Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT03661307Genetically Engineered Cells (CD83 CAR T Cells) for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06871410A Phase I-II Study Investigating the All-Oral Combination of the Menin Inhibitor SNDX-5613 With Decitabine/Cedazuridine (ASTX727) and Venetoclax in Acute Myeloid Leukemia (SAVE)
Nagre-recruitPhase 1/2Malugod na tinatanggap ang malusog na boluntaryo
Edad 12 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT05360160A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia
Nagre-recruitPhase 1
Hanggang edad 21 · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07012044Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06317649A Study of CRD3874-SI in People With Leukemia
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07661095Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.